On August 11, 2023, Citadel Advisors LLC, a renowned investment firm, made a significant move in the stock market by acquiring a new stake in Benitec Biopharma Inc. This article provides an in-depth analysis of this transaction, the profiles of both Citadel Advisors LLC and Benitec Biopharma Inc, and the potential implications for value investors. Citadel Advisors LLC purchased 173,880 shares of Benitec Biopharma Inc at a price of $2.81 per share. This transaction marked a new holding for the firm, increasing their total shares in Benitec Biopharma Inc to 173,880.